RVNC
Revance Therapeutics Inc
Price:  
3.02 
USD
Volume:  
2,189,624.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RVNC DCF Valuation - Growth Exit 5Y

-7929.5%
Upside

The Discounted Cash Flow (DCF) valuation of Revance Therapeutics Inc (RVNC) is (236.45) USD. With the latest stock price at 3.02 USD, the upside of Revance Therapeutics Inc based on DCF is -7929.5%.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
WACC / Discount Rate 8.0% - 9.9% 8.9%
Long-term Growth Rate 3.0% - 5.0% 4.0%
Fair Price (378.98) - (174.55) (236.45)
Upside -12649.0% - -5879.8% -7929.5%
3.02 USD
Stock Price
(236.45) USD
Fair Price